PIPELINES

Site-agnostic Cancer Diagnostics Pipelines

Tests and Assays planned for 2019 - 2020

Product name Biomarker Detection methods(Status) Indication in development
TumorScreen Anti- PKA Cα antibody ELISA & Rapid High priority targets: ovarian cancer, prostate cancer, breast cancer
TumorScreen (Ver2) Anti- PKA Cα antibody combination with other universal cancer biomarkers Preclinical Various cancers

Instruments/devices planned for 2019 -2021

Product name Description
TumorScreen single reader Quantification of Anti- PKA Cα antibody
BG product semi/full automation Automation reader system to conduct BG’s diagnostic test series

Business

#3, 620, Samseong-ro, Gangnam-gu, Seoul,06085, Korea

TEL : +82-70-5096-5936

FAX : +82-2-569-7644

EMAIL : business@biogemex.com

R&D

#317, Hyundai I-Valley, 31, Galmachi-ro 244beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13212, Korea

TEL: +82-70-7753-2260

FAX : +82-31-737-9806

EMAIL: rnd@biogemex.com

Manufacture

#318, Hyundai I-Valley, 31, Galmachi-ro 244beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13212, Korea

TEL : +82-31-737-9800

FAX : +82-31-737-9806

EMAIL : manufacture@biogemex.com